Structures by: Kang G.
Total: 44
C12H8Cu2N2O8
C12H8Cu2N2O8
CrystEngComm (2015) 17, 8 1871
a=18.211(3)Å b=5.1283(10)Å c=13.915(3)Å
α=90.00° β=96.803(2)° γ=90.00°
C12H12Cu2N2O10
C12H12Cu2N2O10
CrystEngComm (2015) 17, 8 1871
a=6.2937(16)Å b=6.8393(17)Å c=9.545(4)Å
α=99.689(4)° β=90.764(4)° γ=116.946(3)°
C38H48Cu2N6O21
C38H48Cu2N6O21
CrystEngComm (2015) 17, 8 1871
a=12.1868(13)Å b=12.4222(13)Å c=15.4307(16)Å
α=77.3990(10)° β=88.5830(10)° γ=85.8840(10)°
C12H10CuN2O8
C12H10CuN2O8
CrystEngComm (2015) 17, 8 1871
a=4.785(7)Å b=9.330(14)Å c=14.53(2)Å
α=89.807(16)° β=81.067(16)° γ=77.496(16)°
C84H89Cd6ClN12O50.5
C84H89Cd6ClN12O50.5
CrystEngComm (2015) 17, 8 1871
a=18.1541(12)Å b=18.1541(12)Å c=27.843(4)Å
α=90.00° β=90.00° γ=120.00°
Pyrazoxyfen
C20H16Cl2N2O3
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 12 o1033
a=7.827(3)Å b=15.534(5)Å c=15.886(6)Å
α=88.82(2)° β=89.093(18)° γ=77.266(18)°
Fenpropathrin
C22H23NO3
Acta Crystallographica Section E (2014) 70, 12 o1265
a=16.2578(4)Å b=6.47990(10)Å c=19.2475(4)Å
α=90.00° β=112.4530(10)° γ=90.00°
<i>N</i>-dichlorofluoromethylthio-<i>N</i>',<i>N</i>'-dimethyl-<i>N</i>-<i>p</i>-tolylsulfamide
C10H13Cl2FN2O2S2
Acta Crystallographica Section E (2014) 70, 10 o1114-o1115
a=23.7638(19)Å b=8.7046(7)Å c=14.6559(11)Å
α=90.00° β=102.133(3)° γ=90.00°
3,6-bis(2-Chlorophenyl)-1,2,4,5-tetrazine
C14H8Cl2N4
Acta Crystallographica Section E (2014) 70, 10 o1135
a=3.8199(4)Å b=14.0706(16)Å c=12.1066(15)Å
α=90.00° β=97.715(3)° γ=90.00°
2-Bromo-4,6-dinitroaniline
C6H4BrN3O4
Acta Crystallographica Section E (2015) 71, 11 o813
a=6.6955(2)Å b=7.7720(2)Å c=16.0608(4)Å
α=90° β=95.4182(14)° γ=90°
Mandipropamid
C23H22ClNO4
Acta Crystallographica Section E (2015) 71, 10 o727-o728
a=26.3733(17)Å b=9.4740(6)Å c=8.4882(5)Å
α=90° β=91.013(3)° γ=90°
4-Cyclopropyl-6-methyl-<i>N</i>-phenylpyrimidin-2-amine
C14H15N3
Acta Crystallographica Section E (2015) 71, 1 o5
a=13.1920(6)Å b=5.3176(2)Å c=16.8641(7)Å
α=90.00° β=100.288(2)° γ=90.00°
Benzobicyclon
C22H19ClO4S2
Acta Crystallographica Section E (2015) 71, 12 o1035
a=15.5111(8)Å b=10.7218(6)Å c=12.0169(6)Å
α=90° β=91.449(3)° γ=90°
2-(4-Chlorophenyl)-3-cyclopropyl-1-(1<i>H</i>-1,2,4-triazol-1-yl)butan-2-ol
C15H18ClN3O
Acta Crystallographica Section E (2015) 71, 12 o1007
a=9.7783(11)Å b=12.2150(13)Å c=14.5861(15)Å
α=107.965(6)° β=108.254(5)° γ=99.533(5)°
Cafenstrole
C16H22N4O3S
Acta Crystallographica Section E (2015) 71, 8 o614
a=7.2800(3)Å b=8.0410(4)Å c=30.1792(13)Å
α=90° β=95.290(3)° γ=90°
Metobromuron
C9H11BrN2O2
Acta Crystallographica Section E (2015) 71, 8 o589
a=9.8184(2)Å b=11.3286(3)Å c=18.9569(5)Å
α=90° β=90° γ=90°
Pyriproxyfen
C20H19NO3
Acta Crystallographica Section E (2015) 71, 8 o588
a=10.0676(2)Å b=8.02790(10)Å c=40.9129(7)Å
α=90° β=90° γ=90°
Nuarimol
C17H12ClFN2O
Acta Crystallographica Section E (2015) 71, 8 o586-o587
a=13.5772(5)Å b=9.3722(4)Å c=22.8756(10)Å
α=90° β=99.974(2)° γ=90°
3-Hydroxy-2-(4-methylsulfonyl-2-nitrobenzoyl)cyclohex-2-enone
C14H13NO7S
Acta Crystallographica Section E (2015) 71, 8 o548-o549
a=10.4208(2)Å b=11.2525(3)Å c=12.3550(3)Å
α=90° β=95.3700(10)° γ=90°
1-({2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1<i>H</i>-1,2,4-triazole
C19H17Cl2N3O3
Acta Crystallographica Section E (2014) 70, 11 o1173
a=25.6913(13)Å b=10.0220(4)Å c=14.6417(6)Å
α=90.00° β=93.439(4)° γ=90.00°
[1,1'-Biphenyl]-2,2'-dicarbonitrile
C14H8N2
Acta Crystallographica Section E (2015) 71, 6 o430
a=15.7839(9)Å b=3.9451(2)Å c=16.6079(9)Å
α=90.00° β=101.630(3)° γ=90.00°
Oryzalin
C12H18N4O6S
Acta Crystallographica Section E (2015) 71, 6 o429
a=7.6057(2)Å b=8.2463(2)Å c=12.8657(2)Å
α=73.9010(10)° β=86.0590(10)° γ=83.5490(10)°
6-Methyl-4-[(<i>E</i>)-(pyridin-3-ylmethylidene)amino]-4,5-dihydro-1,2,4-triazin-3(2<i>H</i>)-one
C10H11N5O
Acta Crystallographica Section E (2015) 71, 7 o461-o462
a=8.0803(2)Å b=23.7497(6)Å c=10.7846(3)Å
α=90.00° β=98.9620(10)° γ=90.00°
Pencycuron
C19H21ClN2O
Acta Crystallographica Section E (2015) 71, 8 o532
a=12.1585(5)Å b=8.6721(4)Å c=32.6152(12)Å
α=90° β=90° γ=90°
5-<i>tert</i>-Butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3<i>H</i>)-one
C15H14Cl2N2O3
Acta Crystallographica Section E (2015) 71, 7 o494
a=12.9132(6)Å b=15.3893(7)Å c=8.4792(4)Å
α=90° β=107.5590(10)° γ=90°
Fenclorim
C10H6Cl2N2
Acta Crystallographica Section E (2015) 71, 10 o714
a=5.6210(6)Å b=17.0659(18)Å c=10.2582(12)Å
α=90° β=99.690(6)° γ=90°
2-Methylsulfanyl-1-(thiomorpholin-4-yl)ethanone
C7H13NOS2
Acta Crystallographica Section E (2015) 71, 9 o679
a=15.0461(15)Å b=6.1525(6)Å c=10.4751(10)Å
α=90° β=107.581(6)° γ=90°
Fenbuconazole
C19H17ClN4
Acta Crystallographica Section E (2015) 71, 9 o680-o681
a=12.4606(3)Å b=6.7404(2)Å c=20.5394(5)Å
α=90° β=95.455(2)° γ=90°
Dimethomorph
C21H22ClNO4
Acta Crystallographica Section E (2015) 71, 9 o654
a=6.6238(2)Å b=13.2232(4)Å c=21.4810(7)Å
α=90° β=97.1674(19)° γ=90°
4,6-Dichloro-<i>N</i>-(2-chlorophenyl)-1,3,5-triazin-2-amine
C9H5Cl3N4
Acta Crystallographica Section E (2014) 70, 9 o923
a=7.2491(9)Å b=7.9910(9)Å c=10.5039(13)Å
α=111.954(6)° β=106.411(6)° γ=90.111(6)°
Diafenthiuron
C23H32N2OS
Acta Crystallographica Section E (2014) 70, 7 o807
a=12.8656(2)Å b=17.9807(3)Å c=10.1671(2)Å
α=90.00° β=102.6550(10)° γ=90.00°
1-[4-(5-chloro-α,α,α-trifluoro-<i>p</i>-tolyloxy)-2-fluorophenyl]-3-(2,6-difluorobenzoyl)urea
C21H11ClF6N2O3
Acta Crystallographica Section E (2014) 70, 10 o1110
a=10.017(2)Å b=10.640(2)Å c=10.677(2)Å
α=62.520(9)° β=75.874(8)° γ=81.831(8)°
C18H20N2
C18H20N2
ACS Catalysis (2020) 1792-1798
a=9.2067(10)Å b=5.9745(7)Å c=24.769(3)Å
α=90° β=91.977(7)° γ=90°
C26H32N2O4S2
C26H32N2O4S2
Crystal Growth & Design (2015) 15, 11 5183
a=16.1825(6)Å b=5.4983(2)Å c=14.0206(5)Å
α=90° β=98.007(2)° γ=90°
C30H38Cu4I4N4O4S2,CHCl3
C30H38Cu4I4N4O4S2,CHCl3
Crystal Growth & Design (2015) 15, 11 5183
a=18.5914(3)Å b=10.5881(2)Å c=23.0469(4)Å
α=90° β=90° γ=90°
C30H34Cu4I4N4O4S2,0.5(C1H2Cl2)
C30H34Cu4I4N4O4S2,0.5(C1H2Cl2)
Crystal Growth & Design (2015) 15, 11 5183
a=18.6134(3)Å b=10.6685(2)Å c=23.1955(4)Å
α=90° β=90° γ=90°
C30H38Cu4I4N4O4S2
C30H38Cu4I4N4O4S2
Crystal Growth & Design (2015) 15, 11 5183
a=9.0974(2)Å b=20.2078(5)Å c=22.1236(6)Å
α=90° β=98.2340(6)° γ=90°
C30H38Cu4I4N4O4S2,0.5(C8H10)
C30H38Cu4I4N4O4S2,0.5(C8H10)
Crystal Growth & Design (2015) 15, 11 5183
a=10.5077(3)Å b=23.0532(5)Å c=18.4486(4)Å
α=90° β=90.4753(10)° γ=90°
C16H19NO2S
C16H19NO2S
Journal of the American Chemical Society (2012) 134, 398-405
a=16.901(3)Å b=9.2889(19)Å c=19.688(4)Å
α=90.00° β=106.99(3)° γ=90.00°
C23H20NO3P
C23H20NO3P
Journal of the American Chemical Society (2019) 141, 23 9239-9248
a=8.7457(6)Å b=9.3045(6)Å c=12.4461(8)Å
α=104.345(2)° β=103.023(2)° γ=90.340(2)°
C22H18NOP
C22H18NOP
Journal of the American Chemical Society (2019) 141, 23 9239-9248
a=8.8392(6)Å b=17.5163(12)Å c=11.7943(8)Å
α=90° β=109.285(2)° γ=90°
C15H16N2O2
C15H16N2O2
Journal of the American Chemical Society (2019) 141, 23 9239-9248
a=14.6899(13)Å b=11.8518(11)Å c=7.5864(6)Å
α=90° β=98.535(3)° γ=90°
C18H16NOP
C18H16NOP
Journal of the American Chemical Society (2019) 141, 23 9239-9248
a=15.0243(18)Å b=9.1417(11)Å c=11.0063(13)Å
α=90° β=92.782(6)° γ=90°
Cyclosulfamuron
C17H19N5O6S
Acta Crystallographica Section E (2015) 71, 8 o631-o632
a=12.7019(4)Å b=9.6216(3)Å c=15.6213(5)Å
α=90° β=93.6194(12)° γ=90°